Skopos Labs, Inc. Halozyme Therapeutics, Inc. Transaction History

Skopos Labs, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$52.92 - $78.28 $519,515 - $768,474	9,817 Added 378.3%	12,412 $910,000
Q2 2025 Aug 14, 2025	BUY	$47.91 - $70.14 $90,166 - $132,003	1,882 Added 263.96%	2,595 $134,000
Q1 2025 May 13, 2025	BUY	$47.74 - $65.16 $31,985 - $43,657	670 Added 1558.14%	713 $45,000
Q4 2024 Jan 15, 2025	BUY	$42.57 - $61.09 $1,830 - $2,626	43 New	43 $2,000

669

128M

599K

455K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $9.75B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

Stay updated on Skopos Labs, Inc. with notifications on news.